from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2652c/-

LFCtreatmentdescriptionclass of inhibitor

0.486

Amikacinug/mL Amikacintranslation

-0.132

Cap5-10ug/mL Capreomycintranslation

0.054

Rox10-50 ug/mL Roxithromycintranslation

1.792

SM2-5 ug/mL Streptomycintranslation

-0.790

Tet5-10 ug/mL Tetracyclinetranslation

0.596

Rif0.2-5ug/mL Rifampicintranscription

-0.368

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.136

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.720

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.372

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.776

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.441

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.612

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.019

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.253

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.349

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.229

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.471

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.538

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.601

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.124

Nigericin50 uM Nigericinrespiration

-0.420

TRC10-150 ug/mL Triclosanrespiration

0.557

TRZ10-25 ug/mL Thioridazinerespiration

1.556

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.914

menadione6-10 ug/mL Menadionerespiration

-0.138

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.352

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.841

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.152

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.831

NRP_1Non-replicating persistence stage 1dosRassociated

-0.523

Amp0.2mg/mL AmpicillincellWall

-0.690

Cephalexin20-100 ug/mL CephalexincellWall

0.661

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.425

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.242

EMB10-20 ug/mL EthambutolcellWall

0.171

Eta12-40 ug/mL EthionamidecellWall

-0.441

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.075

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.667

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.156

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.040

BZA0.12 mg/mL BenzamidearomaticAmides

0.811

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.188

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.895

H2O24 mM hydrogen peroxideDNAdamaging

-0.288

Levo10 ug/mL LevofloxacinDNAdamaging

0.973

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.800

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.393

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.626

UVUV-irradiationDNAdamaging

-0.451

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.807

Antimycin12.5-50 ug/mL Antimycin A?

-1.073

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.028

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.217

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.546

PA8240.2-2 ug/mL PA-824?

-0.142

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.102

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.273

Verapamil50 uM Verapamil?

-0.701

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.809

methoxatin10-20 ug/mL Methoxatin?